祥生醫療(688358.SH)獲2項醫療器械註冊證
格隆匯8月20日丨祥生醫療(688358.SH)公佈,公司於近日收到由江蘇省藥品監督管理局頒發的2項《醫療器械註冊證》。產品名稱“全數字掌上彩色多普勒超聲診斷儀”、“全數字掌上彩色多普勒超聲診斷儀”。
隨着便攜超聲產品在醫學診斷領域應用的不斷擴展,芯片小型化技術、低功耗技術的日趨成熟,臨牀應用對超聲設備的便攜性、小型化提出了更高要求,掌上超聲作為新型的便攜小型化超聲產品,應用已涉及重症監護、急診、麻醉、疼痛、腎內等科室,成為醫用診斷的重要設備之一,也是全球醫療器械產業中增長較快的產品類型之一。
此次獲得註冊的SonoEye系列產品系迄今為止公司便攜小型化產品中重量最輕、體積最小的超聲產品。該系列產品的推出,有利於進一步提高公司在便攜小型化和專科超聲診斷領域的市場競爭力,對於公司產品在國內市場的推廣和銷售將起到積極推動作用。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.